Research article · 15 Apr 2026
Brief reportPublished 31 Jan 2025
Association between MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
MOTS-c, a mitochondrial-derived peptide, has garnered significant attention for its role in metabolic regulation, cellular homeostasis, and muscle maintenance. In chronic peritoneal dialysis patients, the risk of sarcopenia is particularly high due to multiple contributing factors, including chronic inflammation, oxidative stress, malnutrition, and prolonged exposure to uraemic toxins. Sarcopenia, characterized by progressive loss of muscle mass and function, significantly affects morbidity and mortality in dialysis patients. Understanding the association between MOTS-c levels and sarcopenia risk could provide valuable insights into potential therapeutic interventions and early diagnostic markers.
Keywords
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Dnako Junashi”
